Cargando…
Parkinson’s disease therapy: what lies ahead?
The worldwide prevalence of Parkinson’s disease (PD) has been constantly increasing in the last decades. With rising life expectancy, a longer disease duration in PD patients is observed, further increasing the need and socioeconomic importance of adequate PD treatment. Today, PD is exclusively trea...
Autores principales: | Wolff, Andreas, Schumacher, Nicolas U., Pürner, Dominik, Machetanz, Gerrit, Demleitner, Antonia F., Feneberg, Emily, Hagemeier, Maike, Lingor, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199869/ https://www.ncbi.nlm.nih.gov/pubmed/37147404 http://dx.doi.org/10.1007/s00702-023-02641-6 |
Ejemplares similares
-
SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
por: Lingor, Paul, et al.
Publicado: (2022) -
Best practice approaches to outpatient management of people living with Parkinson’s disease during the COVID-19 pandemic
por: Demleitner, Antonia F., et al.
Publicado: (2022) -
Long‐Lasting Impact of the COVID‐19 Pandemic on Patients with Parkinson's Disease and Their Relatives
por: Wolff, Andreas Wolfgang, et al.
Publicado: (2023) -
The heterogeneity of Parkinson’s disease
por: Wüllner, Ullrich, et al.
Publicado: (2023) -
Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice
por: Tönges, Lars, et al.
Publicado: (2022)